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Requirement of 3 '-Terminal Poly(adenylic acid) for the Infectivity
of Poliovirus RNA
Iribonuclease H/removal of poly(A)J
DEBORAH H. SPECTOR AND DAVID BALTIMORE
Department of Biology, Massachusetts Institute of Technology, 77 Massachusetts Avenue, Cambridge, Mass. 02139
Contributed by David Baltimore, May 16, 1974
ABSTRACT Ribonuclease H (EC 3.1.4.34) has been
used to remove selectively much of the 3'-terminal poly-
(adenylic acid) [poly(A)J from poliovirus RNA by treating
the RNA with the enzyme in the presence of poly(dT).
Over 80% of the poly(A) could be removed and the re-
siduum was found as oligo(A) stretches attached to many
or all of the viral RNA molecules. Reduction of the size of
the poly(A) markedly decreased the specific infectivity of
poliovirus RNA, indicating that poly(A) is necessary to the
infectivity of the RNA. The virions in plaques deriving
from infection with treated RNA have a normal amount
and size of poly(A), indicating that mechanisms exist in
infected cells to regenerate normal length poly(A) from
truncated poly(A).
Sequences of poly(A) are found covalently linked to the mes-
senger RNA and heterogenous nuclear RNA of eukaryotic
cells, to mitochondrial RNA of HeLa cells, and to the genome
of one plant and several mammalian single-stranded RNA
viruses (1-3). The biological function of these 3'-terminal
poly(A) sequences, however, is unknown. It has been sug-
gested that they may play some role either in the processing
and transport of messenger RNA from the nucleus to the
cytoplasm or in the translation of the messenger RNA (4, 5).
The single-stranded RNA genome of poliovirus also has
a sequence of poly(A) at its 3'-terminus (4, 6). Whereas the
addition of poly(A) to nuclear RNA appears to be post-
transcriptional (1), poliovirus poly(A) seems to be transcribed
because an appropriate length of poly(U) can be recovered
from the viral replicative form (7) and replicative intermedi-
ate (D. H. Spector; Y. Yogo and E. Wimmer, unpublished
results). The fact that the genome of poliovirus RNA is infec-
tious and serves both as messenger RNA for the synthesis of
virus specific protein and as a template in viral RNA replica-
tion (8) makes it an excellent source of homogeneous RNA
for studies on the mechanism of synthesis and function of
poly(A).
In this study we have utilized a highly purified RNase H
(EC 3.1.4.34) from Escherichia coli (W. Keller, manuscript
in preparation), to digest selectively poliovirus 3'-terminal
poly(A) that has been hybridized with poly(dT). The evi-
dence, suggests that the poly(A) on poliovirus RNA serves a
critical biological function, because removal of much of the
poly(A) reduces the infectivity of the RNA. Furthermore, a
mechanism appears to exist in the infected cell that can re-
generate full-size poly(A) on progeny viral RNA molecules.
MATERIALS AND METHODS
Cell Culture, Infection, and Labeling of Viral RNA. The
growth of suspended HeLa cells in Joklik modified minimal
essential medium plus 7% horse serum and their infection by
type 1 poliovirus in the presence of 10 ,sg/ml of actinomycin D
has been described (9). To label viral RNA, 75 ,uCi/ml [2,8-
3H]adenosine was added 1 hr after infection. Five hours later
a cytoplasmic extract was prepared by Dounce homogeniza-
tion (10).
For isolation of labeled virus, the cytoplasmic extract was
adjusted to 10 mM ethylenediaminetetraacetate (EDTA),
1% sodium dodecyl sulfate (NaDodSO,), 2 M LiCl, and
placed at -20° overnight. Single-stranded and partially
double-stranded RNA were removed by centrifugation, and
the supernatant containing virions and double-stranded RNA
was layered over a 35-ml linear 15-30% sucrose gradient in
0.5% NaDodSO4 buffer (0.1 M NaCl; 0.01 M Tris-HCl, pH
7.5; 1 mM EDTA, 0.5% NaDodSO4) and centrifuged at 220
for 2.5 hr at 95,000 X g in the SW 27 rotor in the L2-65 13
Spinco ultracentrifuge.
RNA, extracted from the purified virions by the NaDodSO4-
acetic acid extraction method (11, 12), was centrifuged
through a 35-ml linear 15-30% sucrose gradient in 0.5% Na-
DodSO4 buffer at 220 for 10.5 hr at 95,000 X g in the SW 27
rotor. The fractions containing viral RNA were pooled, made
0.4 M in sodium acetate and 50% in ethanol and placed at
_20' overnight. The ethanol-precipitated RNA was collected
by centrifugation at 100 for 6 hr at 95,000 X g in the SW 27
rotor. The precipitated RNA was resuspended in 0.5 ml of
5.0 mM EDTA, pH 7.0, and 0.1-ml aliquots were stored at
-70°. By this procedure poliovirus RNA was obtained with a
specific activity of from 5.1 to 6.5 X 105 cpm/,ug.
RNase H Treatment of Poliovirus RNA. RNase H in 0.01
potassium phosphate pH 7.0, 0.2 M potassium chloride, 0.1
mnM EDTA, 1 mM dithiothreitol, and 10% glycerol was
kindly supplied by Walter Keller, Cold Spring Harbor. The
concentration of the enzyme was not known, so the necessary
quantities were determined empirically as the amount required
to produce a limit digest of [3H]poly(A) . poly(dT). The re-
action mixture of 1.3 ml contained 50 mM Tris- HCl, pH 7.9,
10 mM Mg acetate, 10% glycerol, 1.0 mM EDTA, 27.2 usg
of polio RNA [equivalent to 1.02 nmoles of poly(A) 1, 340
pmoles of poly(dT), and 20 X of enzyme (omitted in "un-
treated" sample). After incubation for 60 min at 270, reac-
tions were terminated by the addition of 0.7 ml of 0.5%
NaDodSO4 buffer, and the RNA was immediately collected by
Abbreviations: RNase H, ribonuclease H (a nuclease only able
to degrade the RNA portion of a DNA- RNA hybrid); NaDodSO4,
sodium dodecyl sulfate; EDTA, ethylenediaminetetraacetate.
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FIG. 1. Sedimentation of RNase H-treated (A) and un-
treated (B) [3H] adenosine-labeled poliovirus RNA after de-
naturation with formamide.
ethanol precipitation. In order to complex the poly(dT), we
resuspended the RNA in 2 ml of 90% formamide with 100 ug
of poly(A) and 2 mM Tris HCl, pH 7.3, and incubated it at
room temperature for 5-10 min. One milliliter of 0.5% Na-
DodSO4 buffer was then added and the samples were ethanol-
precipitated. The RNA was resuspended in 0.5% NaDodSO4
buffer, layered over a linear 15-30% sucrose gradient in 0.5%
NaDodSO4 buffer, and centrifuged at 22° for 10.5 hr at 95,000
X g in the SW 27 rotor (Fig. 1). The 35S RNA was collected,
pooled, ethanol-precipitated1 and resuspended in 5.0 mM
EDTA, pH 7.0.
Poly(U) Binding of Viral RNA. Poly(U)-containing glass
fiber filters were prepared and used according to a modifica-
tion of the techniques of Sheldon et al. (13). Labeled RNA
dissolved in 1 nil of binding buffer (0.3 M NaCl, 0.01
M Tris- HCl, 0.5% NaDodSO4, pH 7.6) was passed
through poly(U) filters. The filters were then extensively
washed with binding buffer, followed by several washings
with a solution of 0.3 M ammonium acetate in 50% ethanol.
The filters were dried and counted in toluene-based scintilla-
tion fluid.
Infectious RNA Assay. The infectious RNA assay was a
combination of the methods of Koch et al. (14) and Ellem
and Colter (15). The assay is linear with RNA concentration
and added excess nonspecific RNA does not compete with
infectious RNA ( D. Gelfand and D. Baltimore, unpublished
results). In the assay, 0.1 ,g of viral RNA in 1 ml of PES
buffer (0.9 M NaCl, 0.02 M sodium phosphate buffer, pH
7.3) was incubated with 107 HeLa cells at 370 for 8 min. The
mixture was diluted 10-fold with growth medium containing
2% horse serum and aliquots of 0.1-1 ml were mixed with 107
indicator HeLa cells suspended in sufficient medium plus 2%o
horse serum to give a final volume of 1.5 ml. Then, 1 ml of
1.4% agar medium was added, and the mixture was poured
onto plates containing a base layer of 15 ml of agar (0.9%
agar in medium plus 5.0% calf serum). Incubation and vis-
ualization of plaques was the same as for the poliovirus plaque
assay which has been described previously (16).
Isolation of Poly(A). ['H]Adenosine-labeled RNA was
treated with 10 ,g/ml of pancreatic ribonuclease and 10
units/ml of T, ribonuclease in 4 ml of 0.3 M NaCl, 0.03 M
Na acetate for 60 min at 370. The reaction was stopped by
the addition of 1.6 ml of a 4 nmg/ml solution of proteinase
K in 0.025 M Tris* HCl pH 7.5. After 10 min at room tem-
perature, the samples were adjusted to 0.5% NaDodSO4 and
incubated for 30-60 min at room temperature. Diethylpyro-
carbonate was then added to 0.5% and the solution was
adjusted to 0.4 M NaCI. The ribonuclease-resistant poly(A)
was then isolated by filtering the solution through poly(U)
filters. Elution of the poly(A)-containing RNA from poly(U)
filters was carried out with two, 1 ml aliquots of 90% form-
amide containing 2 mM Tris and 100 /Ag/ml of poly(A) at
650. The poly(A) was ethanol-precipitated with 100 Iug of
carrier yeast RNA. The radioactivity remaining on the
poly(U)-filters was determined by drying the filters and de-
termining their radioactivity using a toluene-based scintilla-
tion fluid.
Acrylamide Gel Electrophoresis of Poly(A). The size of
poly(A) samples eluted from poly(U) filters was determined
by electrophoresis through 10% acrylamide gels at 7.5 mA
per gel for 5.5 hr (17). 32P-labeled Dictyostelium 4S and 5S
RNA (kindly provided by Bambi Young) were used as
markers and bromophenol blue served as the tracking dye.
Slices (2 mm) were taken and counted in toluene-based
scintillation fluid containing 3.5% NCS (Nuclear Chicago
Solubilizer).
Materials. Actinomycin D was a generous gift from Merck,
Sharp and Dohme. [2,8-3H]Adenosine (34.2 Ci/mmol) was
purchased from New England Nuclear Corp.; pancreatic
ribonuclease (ribonuclease A) and ribonuclease T, from
Worthington Biochemical Corp.; poly(A) and poly(U) from
Miles Laboratories; sodium dodecyl sulfate and formamide
from Matheson, Coleman, and Bell; diethylpyrocarbonate,
acrylamide and N,N-methylene bisacrylamide from Eastman;
and proteinase K fromEM Laboratories.
RESULTS
RNase H Treatment of Poliovirus RNA. The requirements
for RNase H activity as measured by acid solubilization of
[3H]poly(A) are summarized in Table 1. Degradation of poly-
(A) required the presence of both poly(dT) and the enzyme.
Furthermore, the presence of a 9-fold excess of poliovirus
RNA did not inhibit the solubilization of the poly(A). This
RNase H preparation was therefore suitable for removing
the poly(A) on poliovirus RNA.
To examine whether the enzyme preparation contained any
endonucleolytic activity, we treated [3H ladenosine-labeled
poliovirus RNA with RNase H. Treated and untreated RNA
TABLE 1. Conditions for RNase H digestion
% Solubilization
Reaction system of [7Hlpoly(A)
Complete 89
Minus poly(dT) 9
Minus enzyme 3
Plus 87 pmoles of poliovirus RNA 92
Reaction conditions were as described in Materials and Methods.
The complete mixture (0.2 ml) consisted of 10 pmoles of [3H]-
poly(A) (synthesized and kindly provided by Stanley Drost),
3.3 pmoles of poly(dT); and 1 ul of a 1/10 dilution of RNase H.
Incubation was for 60 min at 270.
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were then exposed to a denaturing solvent (90% formamide, 2
mM Tris HCl, pH 7.3) in the presence of 100 lug of poly(A),
which would complex the poly(dT) used in the RNase H
treatment. The RNA samples were then analyzed in sucrose
gradients (Fig. 1). Both preparations show only minimal
degradation. The untreated and treated 35S RNA's from this
experiment were then pooled (see Fig. 1) and used for further
studies.
Poly(U) Binding of RNase H-Treated RNA. To study the
fate of the poly(A) sequences on RNase H-treated poliovirus
RNA, we assayed binding of the RNA to poly(U) filters
(Table 2, Exp. I). Untreated RNA bound to the filters with
an average efficiency of 60%, while the treated RNA bound
with an average efficiency of 8.3%. These values represent
minimum estimates of binding because the untreated viral
RNA molecules that pass through poly(U) filters contained
poly(A) sequences of the same size as those found on RNA
molecules that were bound to the filters (D. H. Spector, un-
published results). It is clear that the RNase H treatment
markedly reduced the ability of poliovirus RNA to bind to
poly(U) filters.
Resistance to Pancreatic plus T1 Ribonucleases. Further
study of the RNase H-treated RNA utilized the resistance of
poly(A) sequences to digestion by pancreatic plus T, RNases.
Treated and untreated, [3H]adenosine-labeled viral RNA
molecules were digested with pancreatic plus T, RNases
and the resistant fraction was assayed by either determining
the remaining acid-precipitable radioactivity or by binding
the RNase-resistant material to poly(U) filters as described
in Materials and Methods (Table 2; Exp. I). Treatment with
RNase H resulted in loss of 83% of the acid-precipitable
poly(U)-binding radioactivity remaining on the viral RNA
molecules.
Size of the Poly(A) Sequences. To determine whether the
17% remaining poly(A) was due to undigested full-length
poly(A) on a few molecules or a residue of short poly(A) on
many or all molecules, we studied the approximate length
of the poly(A) sequences on the treated and untreated RNA.
The poly(A) that resisted treatment with pancreatic plus
T, RNases and that bound to poly(U) filters was subjected
to electrophoresis in 10% polyacrylamide gels (Fig. 2A and
B). The poly(A) from the untreated RNA showed a hetero-
geneous distribution. From the positions of the 4S and 5S
RNA markers, it was estimated that this untreated poly(A)
is approximately 50 to 125 nucleotides in length. This es-
timate agrees with determinations by other methods (ref.
6; and D. H. Spector, unpublished results). The poly(A)
from the treated RNA (Fig. 2B), however, showed only a
sharp peak of oligo(A), less than 40 nucleotides in length.
The small peak of radioactivity in fractions 69-75 (Fig. 2A
and B) appears in both RNase H-treated and untreated
preparations of poly(A) and probably represents either an
oligonucleotide contaminant or a small internal stretch of
poly(A).
From the electrophoretic analysis it appears that the
pancreatic. plus T, RNase-resistant [3H]adenosine label in
viral RNA that is not degraded by RNase H represents oligo-
(A) left on many or all of the molecules and not full-length
undigested poly(A). The amount of radioactivity in full-
length poly(A) is at the very most 300 cpm in the experiment
shown in Fig. 2B. It is our experience that the minimal re-
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FIG. 2. Polyacrylamide gel electrophoresis of the poly(A)
sequences in the RNase H-treated and untreated RNA. [3H]-
Adenosine labeled untreated RNA (A) and R.Nase H-treated
RNA (B) from Experiment I and RNase H-treated RNA (C)
from Experiment II were digested with pancreatic plus T,
RNases, bound to poly(U) filters, and eluted as described in
Materials and Methods. The ethanol-precipitated poly(A) was
dissolved in 100lO of solution of 50% formamide, 25% glycerol,
0.04 M Tris-HCl, pH 7.2, 0.02 M Na acetate, 1 mM EDTA,
and 0.2% NaDodSO4 and subjected to electrophoresis in 10%
polyacrylamide gels at 7.5 mA per gel for 5.5 hr (A and B) or 4.5
hr (C). Slices (2 mm) were counted in toluene-based scintillation
fluid containing 3.5% Nuclear Chicago Solubilizer (B and C).
For gel A the 2-mm slices were placed in 1 ml of a solution con-
taining 0.5 M Na acetate, 1 mM EDTA, 0.2% NaDodSO4, pH
7.0, and shaken for 12 hr at 370, after which 0.2-ml aliquots from
odd-numbered fractions were counted in Aquasol.
Proc. Nat. Acad. Sci. USA 71 (1974)
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TABLE 2. Binding to poly(U) filters and resistance to pancreatic and T1 RNase of RNase H-treated and
untreated poliovirus RNA
Experiment II
Experiment I Treated with RNase
Treated Untreated Treated Untreated H minus poly(dT)
Percent of binding to
poly(U) 8.3 (4.5-12) 60 (55-72) 20 (16; 25) 64 (50; 78) 62 (47; 78)
Percent RNase-resistant 0.78 4.6
Percent of untreated 17 100
Percent RNase-resistant 0.42 (0.35-0.49) 2.4 (2.3-2.5) 0. 91 (0. 82; 1. 0) 2. 3 (2. 2; 2. 3) 2. 2 (2. 1; 2. 3)
and poly(U) bound
Percent of untreated 17.5 100 39.5 100 96
Values in parentheses represent individual determinations or the range of 3 or 4 determinations; each determination involved a separate
RNase H digestion.
covery of full-length poly(A) under these conditions is 47%.
If 17% of the molecules had had full size poly(A) we would
have expected at least 3000 cpm in this region of the gel.
Therefore, at most 2% of the treated RNA molecules have
full size poly(A). From these results we conclude that RNase
H treatment of poliovirus RNA almost completely eliminates
the long stretches of poly(A) on poliovirus RNA but leaves a
residual stretch of oligo(A).
Infectivity of RNase H-Treated RNA. To assay whether
the poly(A) sequences on the poliovirus RNA molecules are
necessary to the infectivity of the molecules, we assayed the
infectivity of RNase H-treated and untreated 35S RNA,
selected from sucrose gradients like those in Fig. 1 (Table 3,
Exp. I). Treatment of viral RNA with RNase H resulted in
more than a 10-fold decrease in infectious titer relative to the
untreated sample, indicating that poly(A) is required in
order for the molecules to be infectious.
TABLE 3. Infectious RNA assay
Experiment I Experiment II
PFU/ % of PFU/ % of
0.01 Un- 0.01 Un-
,ug RNA treated jug RNA treated
Treated
Trial 1 40 102 16.5
6.7
Trial 2 46
Untreated
Trial 1 700 620 (100)
(100)
Trial 2 600
Treated with RNase - 660 106
H minus poly(dT)
Treated and poly(U)-
bound 190 29
Untreated and
poly(U)-bound 725 113
The conditions for testing the infectivity of the RNase H-
treated and untreated RNA and the procedure for the binding
and elution of poliovirus RNA from poly(U) filters are described
in Materials and Methods. Each trial represents the average of
eight samples; the two trials represent separate RNase H diges-
tions.
When the RNase H-treated molecules were first preselected
on poly(U) filters, the specific infectivity of the untreated
RNA was unaffected, while that of the treated RNA in-
creased 4-fold. However, even after preselection on poly(U)
filters, the specific infectivity of the treated preparation was
still only 29% that of the untreated RNA. Thus it would
appear that a sequence of poly(A) of sufficient length to
permit poliovirus RNA to bind to a poly(U) filter is not neces-
sarily sufficient to allow the molecule to be infectious.
In a second set of experiments we utilized a different batch
of RNase H which removed the poly(A) less efficiently from
poliovirus RNA molecules. Pancreatic and T1 RNase diges-
tion of the RNA treated with this RNase H preparation in-
dicated that only 60% of the poly(A) had been removed
(Table 2, Exp. II). This RNase H-treated RNA bound to
poly(U) filters with an average efficiency of 20% (Table 2,
Exp. II), and its specific infectivity was 16.5% of that of the
untreated RNA (Table 3, Exp. II). Electrophoretic analysis
of the pancreatic and T1 RNase-resistant [3H ]adenosine
label remaining on the RNase H-treated molecules (Fig. 2C)
indicated that as many as 8% of the molecules had full size
poly(A), while the majority of the adenosine label migrated
as a relatively homogeneous fraction just ahead of the dye
marker. Furthermore, this set of experiments demonstrated
that the RNase H treatment of RNA in the absence of
poly(dT) caused no detectable change in the RNA. RNA
treated with the enzyme alone had the same ability to bind
to poly(U) filters, the same percentage of RNase-resistance,
and the same specific infectivity as untreated RNA (Tables
2 and 3, Exp. II).
The combined data of the two experiments showed a
correlation between the amount of residual poly(A) on the
RNA molecules after RNase H treatment and the level of
residual infectivity of the molecules. In Experiment I, the
removal of 82% of the poly(A) radioactivity reduced the
specific infectivity to 6.7% of normal; in Experiment II
the removal of 60% of the poly(A) radioactivity reduced the
infectivity to 16.5% of normal.
Characterization of Virus Resulting from Infection with
RNase H-Treated RNA. Five plaques arising from the
RNase H-treated RNA in Experiment I were used to pre-
pare [3H]adenosine-labeled viral RNA. The poly(A) from
all five preparations was indistinguishable in size from the
poly(A) on viral RNA produced by plaques arising from
Proc. Nat. Acad. Sci. USA 71 (1974)
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untreated RNA. Since there was 3-fold greater residual in-
fectivity on the treated molecules than there was full-length
poly(A), the chance that all five plaques arose from molecules
containing full length poly(A) is 3-5 and, therefore, it would
appear that mechanisms exist in the infected cell to regenerate
full-length poly(A) from truncated molecules.
DISCUSSION
From the data presented here we conclude that the 3'-
terminal sequence of adenylic acid residues on poliovirus
RNA is important to the infectivity of the molecule. This
conclusion rests on the ability of RNase H in the presence of
poly(dT) to remove only the poly(A) from the molecules.
The nuclease appears to make no endonucleolytic scissions
in the viral RNA since, after treatment with the enzyme
followed by denaturation, the RNA molecules remain intact
(Fig. 1). Furthermore, treatment with RNase H in the ab-
sence of poly(dT) does not affect the specific infectivity of
35S RNA molecules, indicating that no other critical altera-
tion of the RNA is produced by the RNase H preparations.
The oligo(A) that remains presumably does so because, after
the enzyme has degraded most of the poly(A), the poly(dT)
can no longer bind to the residual oligo(A) and the oligo(A)
is therefore not degraded by the RNase H.
The absolute length of poly(A) needed for infectivity is not
known. The fact that even poly(U) selection of RNase H-
treated molecules reveals a population of molecules that has a
specific infectivity lower than normal suggests that a fairly
long stretch of poly(A) is needed. The role of the poly(A)
is not known; it could even be that it is needed for naked
RNA to be infectious but would not be needed if poly(A)-
deficient RNA were encapsidated.
It is apparent from analysis of the data that the percent
residual infectivity of the RNase H-treated RNA is two to
four times above the percent of RNA molecules with normal
size poly(A). Reconstruction experiments have indicated
that the treated RNA does not enhance the infectivity of un-
treated molecules (D. Spector, unpublished results), so the
excess infectivity appears to result from molecules deficient
in poly(A). When five plaques arising from treated RNA
were analyzed, the progeny had normal size poly(A). Ap-
parently the infected cell is able to regenerate full-size
poly(A) on some of the treated molecules. Virus-specific or
cellular enzymes might be responsible for lengthening the
poly(A).
Various hypotheses concerning the role of poly(A) in the
processing, selection, or transport to the cytoplasm of nuclear
RNA or in the translation of mRNA have been proposed
(4, 5). The findings that histone mRNA has no poly(A)
(18), that some viruses that replicate solely on the cytoplasm
have poly(A) (1), and that removal of poly(A) segments from
poliovirus RNA, and from species of mRNA that were pre-
viously polyadenylylated, does not affect the in vitro trans-
lational capacity of the RNA (refs. 19 and 20; D. H. Spector,
L. Villa-Komaroff, and D. Baltimore, unpublished results)
seem to indicate that in their simplest form these various
hypotheses do not explain poly(A) function. The experiments
presented in this paper represent the first direct demonstra-
tion of a biological function for 3'-terminal poly(A) on an
RNA. Since the intracellular steps of poliovirus replication
have been well documented (6), the use of deadenylylated
poliovirus RNA in one-step growth experiments should help
clarify more precisely the function of the poly(A).
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